Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?

Abstract : The paper deals with the determinants of worldwide IP coverage of patented inventions in large pharmaceutical firms. We support the core idea that the internationalisation of firm R&D and an economic presence in a foreign country are positive key factors which explains global IP coverage. For the global pharmaceutical industry, we estimate probit models on the probability that a patent will be expanded worldwide. We retain two categories of worldwide patent: the well-known triadic patent and the new triadic one (triadic + China + Korea). The data set encompasses the 17,633 priority patents applied for by 76 enterprises from several countries over the period 2003-2005. One important finding is that patenting in Japan sets up an important barrier, giving Japanese firms an advantage when triadic patenting is considered. For European and US firms, our estimation results confirm the idea that the level of firm R&D internationalisation is a significant explanatory factor in international IP coverage, together with control variables. We highlight an inverted U-shaped relationship between these two variables. The hypothesis related to a firm economic presence is also verified.
Type de document :
Article dans une revue
International Journal of Technology Management, Inderscience, In press
Liste complète des métadonnées

Littérature citée [52 références]  Voir  Masquer  Télécharger

https://hal.archives-ouvertes.fr/hal-01725229
Contributeur : Patricia Laurens <>
Soumis le : mercredi 7 mars 2018 - 11:32:22
Dernière modification le : jeudi 5 juillet 2018 - 14:45:33
Document(s) archivé(s) le : vendredi 8 juin 2018 - 13:05:45

Fichiers

IP internationalisation_2017.p...
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : hal-01725229, version 1

Collections

Citation

Patricia Laurens, Christian Le Bas, Antoine Schoen. Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?. International Journal of Technology Management, Inderscience, In press. 〈hal-01725229〉

Partager

Métriques

Consultations de la notice

120

Téléchargements de fichiers

563